Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Nov;92(5):2480–2488. doi: 10.1172/JCI116856

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

Z Liu 1, L A Diaz 1, J L Troy 1, A F Taylor 1, D J Emery 1, J A Fairley 1, G J Giudice 1
PMCID: PMC288433  PMID: 7693763

Abstract

Subepidermal blistering associated with the human skin diseases bullous pemphigoid and herpes gestationis has been thought to be an IgG autoantibody-mediated process; however, previous attempts to demonstrate the pathogenicity of patient autoantibodies have been unsuccessful. An immunodominant and potentially pathogenic epitope associated with these blistering diseases has recently been mapped to the extracellular domain of a human epidermal antigen, BP180. Patient autoantibodies that react with this well-defined antigenic site failed to crossreact with the murine form of this autoantigen and thus could not be assayed for pathogenicity in a conventional passive transfer mouse model. As an alternative, rabbit polyclonal antibodies were generated against a segment of the murine BP180 protein homologous with the human BP180 autoantibody-reactive site and were passively transferred into neonatal BALB/c mice. The injected animals developed a subepidermal blistering disease that closely mimicked bullous pemphigoid and herpes gestationis at the clinical, histological, and immunological levels. Autoantibodies that recognize the human BP180 ectodomain are therefore likely to play an initiatory role in the pathogenesis of bullous pemphigoid and herpes gestationis.

Full text

PDF
2480

Images in this article

2481Image
on p.2481
2481Image
on p.2481
2482Image
on p.2482
2483Image
on p.2483
2484Image
on p.2484
2484Image
on p.2484
2486Image
on p.2486
2486Image
on p.2486
2486Image
on p.2486

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anhalt G. J., Bahn C. F., Labib R. S., Voorhees J. J., Sugar A., Diaz L. A. Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest. 1981 Oct;68(4):1097–1101. doi: 10.1172/JCI110333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anhalt G. J., Diaz L. A. Animal models for bullous pemphigoid. Clin Dermatol. 1987 Jan-Mar;5(1):117–125. doi: 10.1016/0738-081x(87)90056-3. [DOI] [PubMed] [Google Scholar]
  3. Anhalt G. J., Labib R. S., Voorhees J. J., Beals T. F., Diaz L. A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982 May 20;306(20):1189–1196. doi: 10.1056/NEJM198205203062001. [DOI] [PubMed] [Google Scholar]
  4. Carruthers J. A., Ewins A. R. Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of the complement-fixing factor. Clin Exp Immunol. 1978 Jan;31(1):38–44. [PMC free article] [PubMed] [Google Scholar]
  5. Chorzelski T. P., Jablonska S., Beutner E. H., Maciejowska E., Jarzabek-Chorzelska M. Herpes gestations with identical lesions in the newborn. Passive transfer of the disease? Arch Dermatol. 1976 Aug;112(8):1129–1131. [PubMed] [Google Scholar]
  6. Diaz L. A., Ratrie H., 3rd, Saunders W. S., Futamura S., Squiquera H. L., Anhalt G. J., Giudice G. J. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest. 1990 Oct;86(4):1088–1094. doi: 10.1172/JCI114812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gammon W. R., Briggaman R. A. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies. J Invest Dermatol. 1988 Apr;90(4):495–500. doi: 10.1111/1523-1747.ep12460971. [DOI] [PubMed] [Google Scholar]
  8. Giudice G. J., Emery D. J., Diaz L. A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol. 1992 Sep;99(3):243–250. doi: 10.1111/1523-1747.ep12616580. [DOI] [PubMed] [Google Scholar]
  9. Giudice G. J., Squiquera H. L., Elias P. M., Diaz L. A. Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest. 1991 Feb;87(2):734–738. doi: 10.1172/JCI115054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hopkinson S. B., Riddelle K. S., Jones J. C. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol. 1992 Sep;99(3):264–270. doi: 10.1111/1523-1747.ep12616615. [DOI] [PubMed] [Google Scholar]
  11. Jordon R. E., Beutner E. H., Witebsky E., Blumental G., Hale W. L., Lever W. F. Basement zone antibodies in bullous pemphigoid. JAMA. 1967 May 29;200(9):751–756. [PubMed] [Google Scholar]
  12. Jordon R. E., Heine K. G., Tappeiner G., Bushkell L. L., Provost T. T. The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest. 1976 Jun;57(6):1426–1431. doi: 10.1172/JCI108412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Karpati S., Stolz W., Meurer M., Braun-Falco O., Krieg T. Herpes gestationis: ultrastructural identification of the extracellular antigenic sites in diseased skin using immunogold techniques. Br J Dermatol. 1991 Oct;125(4):317–324. doi: 10.1111/j.1365-2133.1991.tb14164.x. [DOI] [PubMed] [Google Scholar]
  14. Katz A., Minto J. O., Toole J. W., Medwidsky W. Immunopathologic study of herpes gestationis in mother and infant. Arch Dermatol. 1977 Aug;113(8):1069–1072. [PubMed] [Google Scholar]
  15. Katz S. I., Hertz K. C., Yaoita H. Herpes gestationis. Immunopathology and characterization of the HG factor. J Clin Invest. 1976 Jun;57(6):1434–1441. doi: 10.1172/JCI108413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kelly S. E., Cerio R., Bhogal B. S., Black M. M. The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody. J Invest Dermatol. 1989 May;92(5):695–698. doi: 10.1111/1523-1747.ep12696884. [DOI] [PubMed] [Google Scholar]
  17. LEVER W. F. Pemphigus. Medicine (Baltimore) 1953 Feb;32(1):1–123. doi: 10.1097/00005792-195302000-00001. [DOI] [PubMed] [Google Scholar]
  18. Labib R. S., Anhalt G. J., Patel H. P., Mutasim D. F., Diaz L. A. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986 Feb 15;136(4):1231–1235. [PubMed] [Google Scholar]
  19. Li K., Tamai K., Tan E. M., Uitto J. Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5'-end of the gene and the 3'-untranslated region of the mRNA. J Biol Chem. 1993 Apr 25;268(12):8825–8834. [PubMed] [Google Scholar]
  20. Liu Z., Diaz L. A., Haas A. L., Giudice G. J. cDNA cloning of a novel human ubiquitin carrier protein. An antigenic domain specifically recognized by endemic pemphigus foliaceus autoantibodies is encoded in a secondary reading frame of this human epidermal transcript. J Biol Chem. 1992 Aug 5;267(22):15829–15835. [PubMed] [Google Scholar]
  21. Marchant J. K., Linsenmayer T. F., Gordon M. K. cDNA analysis predicts a cornea-specific collagen. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1560–1564. doi: 10.1073/pnas.88.4.1560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Morrison L. H., Labib R. S., Zone J. J., Diaz L. A., Anhalt G. J. Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest. 1988 Jun;81(6):2023–2026. doi: 10.1172/JCI113554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mutasim D. F., Takahashi Y., Labib R. S., Anhalt G. J., Patel H. P., Diaz L. A. A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol. 1985 Jan;84(1):47–53. doi: 10.1111/1523-1747.ep12274684. [DOI] [PubMed] [Google Scholar]
  24. Naito K., Morioka S., Ikeda S., Ogawa H. Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement, and migrating cells. J Invest Dermatol. 1984 Mar;82(3):227–230. doi: 10.1111/1523-1747.ep12260057. [DOI] [PubMed] [Google Scholar]
  25. Nishizawa Y., Uematsu J., Owaribe K. HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem. 1993 Apr;113(4):493–501. doi: 10.1093/oxfordjournals.jbchem.a124072. [DOI] [PubMed] [Google Scholar]
  26. Provost T. T., Tomasi T. B., Jr Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest. 1973 Jul;52(7):1779–1787. doi: 10.1172/JCI107359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Roscoe J. T., Diaz L., Sampaio S. A., Castro R. M., Labib R. S., Takahashi Y., Patel H., Anhalt G. J. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol. 1985 Dec;85(6):538–541. doi: 10.1111/1523-1747.ep12277362. [DOI] [PubMed] [Google Scholar]
  28. Sams W. M., Jr, Gleich G. J. Failure to transfer bullous pemphigoid with serum from patients. Proc Soc Exp Biol Med. 1971 Apr;136(4):1027–1031. doi: 10.3181/00379727-136-35421. [DOI] [PubMed] [Google Scholar]
  29. Schaumburg-Lever G., Rule A., Schmidt-Ullrich R., Lever W. F. Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid--a preliminary report. J Invest Dermatol. 1975 Jan;64(1):47–49. doi: 10.1111/1523-1747.ep12540902. [DOI] [PubMed] [Google Scholar]
  30. Shornick J. K., Bangert J. L., Freeman R. G., Gilliam J. N. Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol. 1983 Feb;8(2):214–224. doi: 10.1016/s0190-9622(83)70027-7. [DOI] [PubMed] [Google Scholar]
  31. Stanley J. R., Tanaka T., Mueller S., Klaus-Kovtun V., Roop D. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest. 1988 Dec;82(6):1864–1870. doi: 10.1172/JCI113803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Suzuki M., Harada S., Yaoita H. Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation. Acta Derm Venereol. 1992 Aug;72(4):245–249. [PubMed] [Google Scholar]
  33. Tanaka T., Korman N. J., Shimizu H., Eady R. A., Klaus-Kovtun V., Cehrs K., Stanley J. R. Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol. 1990 May;94(5):617–623. doi: 10.1111/1523-1747.ep12876200. [DOI] [PubMed] [Google Scholar]
  34. Van de Wiel A., Hart H. C., Flinterman J., Kerckhaert J. A., Du Boeuff J. A., Imhof J. W. Plasma exchange in herpes gestationis. Br Med J. 1980 Oct 18;281(6247):1041–1042. doi: 10.1136/bmj.281.6247.1041-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES